Kala Pharmaceuticals Inc (KALA) Insider Trading
- $110,097,301.61
- $1,820,396.36
- June 26, 2024
- Orbimed Advisors Llc
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 26, 2024 | Insider | 4,653 | $4.75 | Sell | $22,101.75 | |
June 26, 2024 | CEO | 15,168 | $4.75 | Sell | $72,048.00 | |
June 26, 2024 | CFO | 4,163 | $4.75 | Sell | $19,774.25 | |
May 31, 2024 | Insider | 2,093 | $6.09 | Sell | $12,746.37 | |
May 31, 2024 | CFO | 1,786 | $6.09 | Sell | $10,876.74 | |
May 31, 2024 | CEO | 7,392 | $6.09 | Sell | $45,017.28 | |
Jan. 4, 2024 | CEO | 4,539 | $6.73 | Sell | $30,547.47 | |
Jan. 4, 2024 | Insider | 1,227 | $6.74 | Sell | $8,269.98 | |
Jan. 4, 2023 | Insider | 60 | $28.55 | Sell | $1,713.00 | |
Jan. 4, 2023 | CEO | 198 | $28.54 | Sell | $5,650.92 | |
Oct. 26, 2022 | Insider | 194 | $6.52 | Sell | $1,264.88 | |
Oct. 26, 2022 | CEO | 561 | $6.52 | Sell | $3,657.72 | |
June 27, 2022 | CEO | 7,975 | $0.37 | Sell | $2,950.75 | |
June 27, 2022 | Insider | 2,613 | $0.37 | Sell | $966.81 | |
May 25, 2022 | Major Shareholder | 1,434,509 | $0.42 | Sell | $602,493.78 | |
May 23, 2022 | Major Shareholder | 1,250,000 | $0.65 | Sell | $812,500.00 | |
Jan. 4, 2022 | CFO | 2,850 | $1.30 | Sell | $3,705.00 | |
Jan. 4, 2022 | Insider | 3,504 | $1.30 | Sell | $4,555.20 | |
Jan. 4, 2022 | CEO | 9,518 | $1.30 | Sell | $12,373.40 | |
Oct. 26, 2021 | Insider | 9,449 | $1.80 | Sell | $17,008.20 | |
Oct. 26, 2021 | CEO | 27,598 | $1.80 | Sell | $49,676.40 | |
Oct. 26, 2021 | COO | 12,544 | $1.80 | Sell | $22,579.20 | |
June 28, 2021 | Insider | 2,452 | $5.77 | Sell | $14,148.04 | |
June 28, 2021 | CEO | 7,586 | $5.77 | Sell | $43,771.22 | |
Oct. 22, 2020 | COO | 40 | $7.60 | Buy | $304.00 | |
June 5, 2020 | COO | 2 | $13.39 | Buy | $26.78 | |
March 16, 2020 | COO | 10,000 | $5.75 | Buy | $57,500.00 | |
March 13, 2020 | Director | 6,337,135 | $7.89 | Buy | $49,999,995.15 | |
May 30, 2019 | Director | 5,000 | $5.42 | Buy | $27,100.00 | |
Oct. 5, 2018 | Director | 606,060 | $8.25 | Buy | $4,999,995.00 | |
Oct. 3, 2018 | Director | 2,424,242 | $8.25 | Buy | $19,999,996.50 | |
Feb. 8, 2018 | Major Shareholder | 25,000 | $12.93 | Buy | $323,250.00 | |
Feb. 1, 2018 | Major Shareholder | 362,240 | $15.00 | Buy | $5,433,600.00 | |
Jan. 29, 2018 | Major Shareholder | 72,760 | $14.97 | Buy | $1,089,217.20 | |
Jan. 26, 2018 | Major Shareholder | 22,760 | $14.93 | Buy | $339,806.80 | |
Jan. 24, 2018 | Major Shareholder | 64,637 | $14.91 | Buy | $963,737.67 | |
Jan. 22, 2018 | Major Shareholder | 75,000 | $14.98 | Buy | $1,123,500.00 | |
Jan. 19, 2018 | Major Shareholder | 74,931 | $14.95 | Buy | $1,120,218.45 | |
Jan. 12, 2018 | Major Shareholder | 240,484 | $13.28 | Buy | $3,193,627.52 | |
Jan. 10, 2018 | Major Shareholder | 170,338 | $12.83 | Buy | $2,185,436.54 | |
July 25, 2017 | Director | 533,333 | $15.00 | Buy | $7,999,995.00 | |
July 25, 2017 | Insider | 319,333 | $15.00 | Buy | $4,789,995.00 | |
July 25, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 | |
July 20, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 |
Insiders are both buying and selling Kala Pharmaceuticals Inc stock.
The insider traders at Kala Pharmaceuticals Inc are: Orbimed Advisors Llc, Mark T Iwicki, Todd Bazemore, Eric Trachtenberg, Mary Reumuth, Rajeev M Shah, Ra Capital Management, L.P., Hongming Chen, Mark T. Iwicki, Gregory Grunberg, Howard B Rosen, Longitude Capital Partners Ii,, Associates L.L.C. Cdk, Ra Capital Healthcare Fund Lp, and Romulus K Brazzell
The most active insider trader at Kala Pharmaceuticals Inc is Orbimed Advisors Llc with 10 trades.
Ra Capital Management, L.P. has sold the most Kala Pharmaceuticals Inc stock with a total value of $2,017,487.56.
Rajeev M Shah has bought the most Kala Pharmaceuticals Inc stock with a total value of $107,999,985.30.
The most recent insider trade for Kala Pharmaceuticals Inc was on June 26, 2024.
The single biggest insider buy for Kala Pharmaceuticals Inc was from Rajeev M Shah with a total value of $49,999,995.15 on March 13, 2020.
The single biggest insider sell for Kala Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $812,500.00 on May 23, 2022.